                </a></li></ul></div><p><strong>Figure 4.  <span>γ promoter methylation pattern in patients with HPFH</span></strong></p><a id="article1.body1.sec2.sec5.fig1.caption1.p1" name="article1.body1.sec2.sec5.fig1.caption1.p1"></a><p>The γ<sup>A</sup> and γ<sup>G</sup> promoter regions were analyzed for CpG methylation on individual clones by the bisulfite technique.</p>
<a id="article1.body1.sec2.sec5.fig1.caption1.p2" name="article1.body1.sec2.sec5.fig1.caption1.p2"></a><p>To this end we used Fibach culture erythroblasts derived from normal individuals, as well as heterozygote HPFH1 or β<sup>0</sup> Thalassemia (IVS-II-I, G⇑A) patients.</p>
<a id="article1.body1.sec2.sec5.fig1.caption1.p3" name="article1.body1.sec2.sec5.fig1.caption1.p3"></a><p>Black circles indicate methylated CpGs, whereas open circles indicate a lack of methylation.</p>
<a id="article1.body1.sec2.sec5.fig1.caption1.p4" name="article1.body1.sec2.sec5.fig1.caption1.p4"></a><p>The numbers in the margin indicate how many clones were fully methylated.</p>
